首页> 美国卫生研究院文献>The Journal of Physiology >Cystic fibrosis transmembrane conductance regulator mediates sulphonylurea block of the inwardly rectifying K+ channel Kir6.1
【2h】

Cystic fibrosis transmembrane conductance regulator mediates sulphonylurea block of the inwardly rectifying K+ channel Kir6.1

机译:囊性纤维化跨膜电导调节剂介导向内整流K +通道Kir6.1的磺酰脲类阻滞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Recombinant ATP-sensitive K+ channels (KATP channels) were heterologously expressed in the NIH3T3 mouse cell line, and the electrophysiological properties were studied using patch-clamp techniques.The NIH3T3 cell lines transfected with the inwardly rectifying K+ channel Kir6.1 alone or with both Kir6.1 and cystic fibrosis transmembrane conductance regulator (CFTR) exhibited time-independent K+ currents with weak inward rectification. In contrast, no measurable K+ conductance was observed in mock-transfected cells or in cells transfected with CFTR alone. Regardless of co-transfection with Kir6.1, the transfection with CFTR produced a Cl conductance that was activated by cell dialysis with cAMP (1 mm). The conductance was reversibly suppressed by glibenclamide (30 μm).Whole-cell currents at +60 mV were blocked in a concentration-dependent manner by Ba2+ ions with similar IC50 values: 89.3 ± 23.3 μm (Kir6.1 alone) and 67.3 ± 24.9 μm (Kir6.1-CFTR).The currents recorded from Kir6.1-transfected cells were not affected by glibenclamide, whereas glibenclamide did inhibit the conductance expressed in cells co-transfected with CFTR (IC50= 35.9 ± 6.6 μm).In the cell-attached mode with a 150 mm K+ pipette solution, both Kir6.1- and Kir6.1-CFTR-transfected cells displayed a class of K+ channels showing weak inward rectification and a slope conductance of 50.7 ± 1.0 and 52.4 ± 4.9 pS, respectively.In the inside-out mode, the single-channel currents recorded from both types of cells were not inhibited by intracellular ATP (1 mm). However, glibenclamide was found to block the single-channel activities in the co-transfected cells.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 重组ATP敏感性K + 通道(KATP通道)在NIH3T3小鼠细胞系中异源表达,并使用膜片钳技术研究其电生理特性。 NIH3T3细胞单独向内整流K + 通道Kir6.1或与Kir6.1和囊性纤维化跨膜电导调节剂(CFTR)一起转染的品系表现出与时间无关的K + 电流内向矫正较弱。相反,在模拟转染的细胞或仅用CFTR转染的细胞中未观察到可测量的K + 电导。无论与Kir6.1共转染,CFTR转染均产生Cl -电导,该电导通过cAMP(1 mm)细胞透析而激活。格列苯脲(30μm)可逆地抑制电导。 Ba 2 + 离子以类似浓度的IC50阻断+60 mV的全细胞电流值:89.3±23.3μm(仅Kir6.1)和67.3±24.9μm(Kir6.1-CFTR)。 格列本脲不影响从Kir6.1转染的细胞记录的电流,而格列本脲确实抑制了CFTR共转染的细胞中表达的电导(IC50 = 35.9±6.6μm)。 在细胞附着模式下,使用150 mm K + 移液器, Kir6.1-和Kir6.1-CFTR转染的细胞均显示出一类K + 通道,这些通道显示出弱的内向整流和斜率电导,分别为50.7±1.0和52.4±4.9 pS。在由内而外的模式下,两种细胞所记录的单通道电流均不受细胞内ATP(1 mm)的抑制。但是,发现格列本脲会阻止共转染细胞中的单通道活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号